Avraham Karasik

Medicine & Life Sciences

1. Type 2 Diabetes Mellitus 100%
2. Insulin 69%
3. Insulin-Like Growth Factor I 56%
4. Israel 50%
5. Phosphorylation 48%
6. Glucose 47%
7. Glucose Intolerance 46%
8. Insulin Receptor 38%
9. Somatomedins 37%
10. Aurintricarboxylic Acid 36%
11. Tyrosine 31%
12. Dipeptidyl-Peptidase IV Inhibitors 30%
13. Epidermal Growth Factor 28%
14. Insulin-Like Growth Factor Binding Protein 3 27%
15. Insulin Receptor Substrate Proteins 27%
16. Insulin-Like Growth Factor Binding Protein 2 27%
17. Acarbose 26%
18. Liraglutide 26%
19. Cardiovascular Diseases 25%
20. Serine 21%
21. Sodium-Glucose Transporter 2 Inhibitors 20%
22. Sitagliptin Phosphate 20%
23. Sodium-Glucose Transport Proteins 19%
24. Proteins 19%
25. Insulin Resistance 18%
26. MCF-7 Cells 18%
27. Hypertension 18%
28. Heart Failure 18%
29. Chronic Renal Insufficiency 18%
30. Serum 17%
31. Laron Syndrome 17%
32. Hepatocytes 16%
33. Hyperinsulinism 16%
34. Metformin 16%
35. Fasting 16%
36. Annexin A1 16%
37. Liver 16%
38. ErbB Receptors 16%
39. Kidney 15%
40. Insulin-Like Growth Factor Binding Proteins 15%
41. Tumor Necrosis Factor-alpha 15%
42. insulin degludec 15%
43. Follicle Stimulating Hormone 15%
44. Cell Death 15%
45. Diabetes Mellitus 15%
46. Granulosa Cells 15%
47. Therapeutics 14%
48. Cohort Studies 14%
49. Obesity 14%
50. Hyperglycemia 14%